from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0066c/icd2

LFCtreatmentdescriptionclass of inhibitor

-0.747

Amikacinug/mL Amikacintranslation

-2.778

Cap5-10ug/mL Capreomycintranslation

-2.548

Rox10-50 ug/mL Roxithromycintranslation

1.300

SM2-5 ug/mL Streptomycintranslation

-2.781

Tet5-10 ug/mL Tetracyclinetranslation

-1.442

Rif0.2-5ug/mL Rifampicintranscription

-1.017

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.614

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.009

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.156

CPZ10-50 ug/mL Chlorpromazinerespiration

0.419

Clofazimine10-13 ug/mL Clofaziminerespiration

0.483

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.464

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.555

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.761

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.337

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.195

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.543

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

2.222

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.330

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.592

KCN5-20 ug/mL Potassium cyaniderespiration

0.570

NaN30.2-2 mM Sodium aziderespiration

-0.421

Nigericin50 uM Nigericinrespiration

-1.130

TRC10-150 ug/mL Triclosanrespiration

0.715

TRZ10-25 ug/mL Thioridazinerespiration

0.041

Valinomycin0.5-10 uM Valinomycinrespiration

0.765

ZnSO42 mM ZnSO4respiration

0.853

menadione6-10 ug/mL Menadionerespiration

0.157

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.325

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.150

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.199

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.581

NRP_1Non-replicating persistence stage 1dosRassociated

0.024

Amp0.2mg/mL AmpicillincellWall

0.086

Cephalexin20-100 ug/mL CephalexincellWall

0.043

Cerulenin0.32-5 ug/mL CerulenincellWall

0.131

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.532

EMB10-20 ug/mL EthambutolcellWall

-0.596

Eta12-40 ug/mL EthionamidecellWall

-0.438

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.062

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.376

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.777

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.825

BZA0.12 mg/mL BenzamidearomaticAmides

0.703

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.839

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.307

H2O24 mM hydrogen peroxideDNAdamaging

-0.666

Levo10 ug/mL LevofloxacinDNAdamaging

0.217

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.287

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.288

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.017

UVUV-irradiationDNAdamaging

-0.386

ARP41-4 ug/mL Antitubercular compound ARP4?

0.502

Antimycin12.5-50 ug/mL Antimycin A?

0.623

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.580

PA_110-50 ug/mL Antitubercular compound PA-1?

0.136

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.506

PA8240.2-2 ug/mL PA-824?

0.766

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.286

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.201

Verapamil50 uM Verapamil?

1.022

mercaptoethanol2 mM 2-Mercaptoethanol?

0.805

methoxatin10-20 ug/mL Methoxatin?